Skip to main content

Table 2 False-positive cases characteristics, pathology of index tumors, and additional primary malignancies, diagnostic procedures, and outcomes

From: Detection of additional primary malignant tumor in cancer survivors: the use of PET/CT for image-guided biopsy

  Age Sex 1 site Path Diagnosis Outcome Interval 2 Path Diagnosis Outcome
22 55 M Liver HCC FNAC RFA 0 GB Cholecystitis FU/US Medical TTT
23 35 F Breast Invasive ductal carcinoma FNAC Lumpectomy/chemotherapy 0 Lung Post pneumonic nodule Biopsy FU
24 32 F Breast Invasive ductal carcinoma FNAC Mastectomy/chemo-radio 6M Colon Colitis Endoscopy Medical TTT
25 28 F Colon Infiltrating adenocarcinoma Endoscopy Colostomy/chemotherapy 0 Breast Fibroadenoma Excision lumpectomy
26 32 F Breast Invasive ductal carcinoma FNAC Lumpectomy/chemo-radio 0 Thyroid Thyroiditis FNAC Medical TTT
27 60 M Colon Adenocarcinoma Endoscopy Colostomy/
chemotherapy
9M adrenal Metachronous
Metastasis
FNAC chemotherapy
28 60 F Lymphoma NHL(LBC) LN. excision Chemotherapy 0 Parotid Pleo-morphic adenoma FNAC Excision
29 45 M Lymphoma NHL(LBC) Tissue biopsy Chemotherapy 0 Colon Colitis Endoscopy Medical TTT
30 54 F Lymphoma NHL(LBC) Tissue biopsy Chemotherapy 1 year Breast Fibroadenoma FNAC Excision